Abciximab Usage in Percutaneous Coronary Intervention in High-Risk Patients: Early and Late Outcomes | Zendy

AI Assistant Blog Pricing

Open Access

Abciximab Usage in Percutaneous Coronary Intervention in High-Risk Patients: Early and Late Outcomes

Author(s) -

Anna Chan,

Wilson Chan,

Chun-Wai Chiu,

Chi-Chiu Kum

Publication year - 2001

Publication title -

deleted journal

Language(s) - English

DOI - 10.55503/2790-6744.1173

Subject(s) - abciximab , percutaneous coronary intervention , conventional pci , medicine , cardiology , adverse effect , percutaneous , myocardial infarction

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.